Optometry News

Dry eye disease is common in glaucoma patients treated with hypotonizing eye drops, with 56.1% of patients reporting subjective signs of dry eye, according to a study in the Open Journal of Ophthalmology.

BARCELONA, Spain — In this Healio Video Perspective from the ESCRS meeting, Federico Badalà, MD, shares his experience with the EyeMax Mono IOL in patients with insignificant cataract and dry age-related macular degeneration.

The Neuro-Optometric Rehabilitation Association has announced that Barbara Barclay will serve as its new executive director starting Oct. 1.

Hormonal therapy may delay glaucoma onset in postmenopausal women, with longer duration of treatment linked to later diagnosis of glaucoma, according to a study in Investigative Ophthalmology & Vision Science.

The FDA granted fast track designation to brepocitinib for the treatment of nonanterior noninfectious uveitis, according to a press release from Priovant Therapeutics.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lisa M. Nijm, MD, JD, offers pearls for young ophthalmologists looking to start a strong career.

The FDA and Palatin Technologies have agreed on protocols and sign and symptom endpoints for the remaining phase 3 clinical trials of PL9643 for dry eye disease, the company announced in a press release.

BARCELONA, Spain — Patients implanted with the Tecnis Eyhance IOL maintain enhanced visual performance for intermediate distance activities after 5 years with constant satisfaction, according to a study.

The American Optometric Association has provided a resource of frequently asked questions and other important details about the updated Eyeglass Rule, which goes into effect Sept. 24.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Anat Loewenstein, MD, MHA, Euretina president, gives an overview of the variety of topics discussed here and the initiatives launched by the society.